CP-137 Economic analysis of azacitidine versus decitabine for the treatment of acute myeloid leukaemia

P Nieto Guindo; H Mateo Carrasco; FD Fernandez Gines; E Molina Cuadrado

doi:10.1136/ejhpharm-2017-000640.136

Article info

Clinical pharmacy

CP-137 Economic analysis of azacitidine versus decitabine for the treatment of acute myeloid leukaemia

Authors

P Nieto Guindo 1Ch Torrecardenas, Pharmacy, Almeria, Spain PubMed articles Google scholar articles
H Mateo Carrasco 2Northampton General Hospital, Pharmacy, Northampton, UK PubMed articles Google scholar articles
FD Fernandez Gines 1Ch Torrecardenas, Pharmacy, Almeria, Spain PubMed articles Google scholar articles
E Molina Cuadrado 3Ch Torrecárdenas, Almeria, Spain PubMed articles Google scholar articles

Citation

Guindo PN, Carrasco HM, Gines FF, et al

CP-137 Economic analysis of azacitidine versus decitabine for the treatment of acute myeloid leukaemia

European Journal of Hospital Pharmacy 2017;24:A61-A62.

Publication history

First published February 25, 2017.

Online issue publication

February 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password